NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email A new survey shows Canadians continue to give a low approval rating of the administration in the United States as the trade war and tariffs continue to sour opinions.Read More